Clinical trial
A Phase II Trial of Losartan to Reverse Sickle Nephropathy
NCT01479439 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of Losartan to Reverse Sickle Nephropathy
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 29, 2012
- Completion date
- December 31, 2015
- Enrollment
- 36 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
nephropathy, sickle cell anemia